Table of Contents Author Guidelines Submit a Manuscript
Critical Care Research and Practice
Volume 2011, Article ID 594645, 6 pages
http://dx.doi.org/10.1155/2011/594645
Research Article

In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between Sepsis and SIRS than CRP, Il-6, or LBP

1Intensive Care Unit of the Reinier de Graaf Groep, Reinier de Graafweg 3-11, 2625AD Delft, The Netherlands
2Department of Medical Immunology of the Reinier de Graaf Groep, Reinier de Graafweg 3-11, 2625AD Delft, The Netherlands
3Department of Microbiology of the Reinier de Graaf Groep, Reinier de Graafweg 3-11, 2625AD Delft, The Netherlands

Received 25 November 2010; Revised 21 February 2011; Accepted 18 March 2011

Academic Editor: Clifford Scott Deutschman

Copyright © 2011 Iwan A. Meynaar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [35 citations]

The following is the list of published articles that have cited the current article.

  • Katharina Biller, Peter Fae, Reinhard Germann, Autar K. Walli, and Peter Fraunberger, “How reliable is procalcitonin as an inflammatory marker?,” Laboratoriumsmedizin-Journal of Laboratory Medicine, vol. 35, no. 6, pp. 343–348, 2011. View at Publisher · View at Google Scholar
  • U. Zielinska-Borkowska, T. Skirecki, M. Zlotorowicz, and B. Czarnocka, “Procalcitonin in early onset ventilator-associated pneumonia,” Journal of Hospital Infection, vol. 81, no. 2, pp. 92–97, 2012. View at Publisher · View at Google Scholar
  • G. N. Matwiyoff, J. D. Prahl, R. J. Miller, J. J. Carmichael, D. E. Amundson, G. Seda, and M. Daheshia, “Immune regulation of procalcitonin: a biomarker and mediator of infection,” Inflammation Research, vol. 61, no. 5, pp. 401–409, 2012. View at Publisher · View at Google Scholar
  • Tomasz Skirecki, Urszula Borkowska-Zielinska, Malgorzata Zlotorowicz, and Grazyna Hoser, “Sepsis Immunopathology: Perspectives of Monitoring and Modulation of the Immune Disturbances,” Archivum Immunologiae Et Therapiae Experimentalis, vol. 60, no. 2, pp. 123–135, 2012. View at Publisher · View at Google Scholar
  • F. Crea, and L. M. Biasucci, “Innate immune inflammatory response to danger: when, how, and why does a friend become a foe?,” European Heart Journal, vol. 33, no. 12, pp. 1434–1437, 2012. View at Publisher · View at Google Scholar
  • Marc Augsburger, Katia Iglesias, Daniel Bardy, Patrice Mangin, and Cristian Palmiere, “Diagnostic value of lipopolysaccharide-binding protein and procalcitonin for sepsis diagnosis in forensic pathology,” International Journal of Legal Medicine, vol. 127, no. 2, pp. 427–435, 2012. View at Publisher · View at Google Scholar
  • Lidija Kitanovski, Janez Jazbec, Sergej Hojker, and Metka Derganc, “Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein,” Supportive Care in Cancer, 2013. View at Publisher · View at Google Scholar
  • Fabian A. Jaimes, Gisela D. De La Rosa, Marta L. Valencia, Clara M. Arango, Carlos I. Gomez, Alex Garcia, Sigifredo Ospina, Susana C. Osorno, and Adriana I. Henao, “A latent class approach for sepsis diagnosis supports use of procalcitonin in the emergency room for diagnosis of severe sepsis,” Bmc Anesthesiology, vol. 13, 2013. View at Publisher · View at Google Scholar
  • Prasanna Sridharan, and Ronald S. Chamberlain, “The Efficacy of Procalcitonin as a Biomarker in the Management of Sepsis: Slaying Dragons or Tilting at Windmills?,” Surgical Infections, vol. 14, no. 6, pp. 489–511, 2013. View at Publisher · View at Google Scholar
  • Ge Tian, Su-yue Pan, Gang Ma, Wei Liao, Quan-guan Su, Bao-chun Gu, and Kun Qin, “Serum levels of procalcitonin as a biomarker for differentiating between sepsis and systemic inflammatory response syndrome in the neurological intensive care unit,” Journal of Clinical Neuroscience, 2013. View at Publisher · View at Google Scholar
  • Andreas Klinger, Michael Buchfelder, Sven Martin Schlaffer, Natalia Kremenevskaja, and Andrea Kleindienst, “Infection surveillance in transsphenoidal pituitary surgery - comparison of lipopolysaccharide-binding-protein, interleukin 6, C-reactive protein, white blood cell count, erythrocyte sedimentation rate and body temperature,” Acta Neurochirurgica, vol. 155, no. 11, pp. 2177–2182, 2013. View at Publisher · View at Google Scholar
  • Sylvia Boenisch, Peter Fae, Heinz Drexel, Autar K. Walli, and Peter Fraunberger, “Are circulating levels of CRP compared to IL-6 and PCT still relevant in intensive care unit patients?,” Laboratoriumsmedizin-Journal Of Laboratory Medicine, vol. 37, no. 1, pp. 1–11, 2013. View at Publisher · View at Google Scholar
  • Christina Wacker, Peter Schlattmann, Anna Prkno, and Frank M. Brunkhorst, “Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis,” Lancet Infectious Diseases, vol. 13, no. 5, pp. 426–435, 2013. View at Publisher · View at Google Scholar
  • K. -F. Bodmann, “Diagnostic markers and assessment of efficacy of antibacterial therapy,” Medizinische Klinik-Intensivmedizin und Notfallmedizin, vol. 109, no. 3, pp. 187–190, 2014. View at Publisher · View at Google Scholar
  • Rakesh S. Engineer, Justin L. Benoit, Srinivasan Dasarathy, Robert H. Christenson, and William F. Peacock, “Procalcitonin as a biomarker for early sepsis in the emergency department,” European Journal of Emergency Medicine, vol. 21, no. 2, pp. 112–117, 2014. View at Publisher · View at Google Scholar
  • M. Sato, H. Nakasone, K. Terasako-Saito, K. Sakamoto, R. Yamazaki, Y. Tanaka, Y. Akahoshi, H. Nakano, T. Ugai, H. Wada, R. Yamasaki, Y. Ishihara, K. Kawamura, M. Ashizawa, S-i Kimura, M. Kikuchi, A. Tanihara, J. Kanda, S. Kako, J. Nishida, and Y. Kanda, “Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation,” Bone Marrow Transplantation, vol. 49, no. 4, pp. 553–560, 2014. View at Publisher · View at Google Scholar
  • Agustin Julian-Jimenez, Francisco Javier Candel-Gonzalez, and Juan Gonzalez del Castillo, “Usefulness of inflammation and infection biomarkers in the Emergency Department,” Enfermedades Infecciosas Y Microbiologia Clinica, vol. 32, no. 3, pp. 177–190, 2014. View at Publisher · View at Google Scholar
  • Labib Debiane, Ray Y. Hachem, Iba Al Wohoush, William Shomali, Ramez R. Bahu, Ying Jiang, Anne-Marie Chaftari, Joseph Jabbour, Munirah Al Shuaibi, Alexander Hanania, S. Egbert Pravinkumar, Philipp Schuetz, and Issam Raad, “The Utility of Proadrenomedullin and Procalcitonin in Comparison to C-Reactive Protein as Predictors of Sepsis and Bloodstream Infections in Critically Ill Patients With Cancer*,” Critical Care Medicine, vol. 42, no. 12, pp. 2500–2507, 2014. View at Publisher · View at Google Scholar
  • Miroslav Prucha, Geoff Bellingan, and Roman Zazula, “Sepsis biomarkers,” Clinica Chimica Acta, 2014. View at Publisher · View at Google Scholar
  • Filippo Pieralli, Carlo Nozzoli, Vieri Vannucchi, Antonio Mancini, Elisa Antonielli, Fabio Luise, Lucia Sammicheli, Valerio Turchi, Ombretta Para, and Francesca Bacci, “Procalcitonin Kinetics in the First 72 Hours Predicts 30-Day Mortality in Severely Ill Septic Patients Admitted to an Intermediate Care Unit.,” Journal of clinical medicine research, vol. 7, no. 9, pp. 706–13, 2015. View at Publisher · View at Google Scholar
  • John Alfred Carr, “Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit,” Journal of Intensive Care, vol. 3, no. 1, 2015. View at Publisher · View at Google Scholar
  • Dimple Anand, Sabari Das, Seema Bhargava, Lalit Mohan Srivastava, Ashish Garg, Niraj Tyagi, Saurabh Taneja, and Sumit Ray, “Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: ,” Journal Of Critical Care, vol. 30, no. 1, 2015. View at Publisher · View at Google Scholar
  • Leo McHugh, Therese A. Seldon, Roslyn A. Brandon, James T. Kirk, Antony Rapisarda, Allison J. Sutherland, Jeffrey J. Presneill, Deon J. Venter, Jeffrey Lipman, Mervyn R. Thomas, Peter M. C. Klein Klouwenberg, Lonneke van Vught, Brendon Scicluna, Marc Bonten, Olaf L. Cremer, Marcus J. Schultz, Tom van der Poll, Thomas D. Yager, and Richard B. Brandon, “A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and ,” Plos Medicine, vol. 12, no. 12, 2015. View at Publisher · View at Google Scholar
  • Jennifer H. Han, Irving Nachamkin, Susan E. Coffin, Jeffrey S. Gerber, Barry Fuchs, Charles Garrigan, Xiaoyan Han, Warren B. Bilker, Jacqueleen Wise, Pam Tolomeo, and Ebbing Lautenbach, “Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial In,” Antimicrobial Agents And Chemotherapy, vol. 59, no. 10, pp. 6494–6500, 2015. View at Publisher · View at Google Scholar
  • Sook Hee Chung, Hye Won Lee, Seung Won Kim, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim, and Jae Hee Cheon, “Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease,” Gut and Liver, vol. 10, no. 4, pp. 574–580, 2016. View at Publisher · View at Google Scholar
  • K. F. Bodmann, M. Schenker, W. Heinlein, and M. H. Wilke, “Procalcitonin als Instrument zur Erfolgsmessung der Therapie einer schweren Sepsis,” Medizinische Klinik - Intensivmedizin und Notfallmedizin, 2016. View at Publisher · View at Google Scholar
  • Brendan J. Kelly, Ebbing Lautenbach, Irving Nachamkin, Susan E. Coffin, Jeffrey S. Gerber, Barry D. Fuchs, Charles Garrigan, Xiaoyan Han, Warren B. Bilker, Jacqueleen Wise, Pam Tolomeo, and Jennifer H. Han, “Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis,” Diagnostic Microbiology And Infectious Disease, vol. 85, no. 1, pp. 109–115, 2016. View at Publisher · View at Google Scholar
  • Kuan-Fu Chen, Chung-Hsien Chaou, Jing-Yi Jiang, Hsueh-Wen Yu, Yu-Hsiang Meng, Wei-Chen Tang, and Chin-Chieh Wu, “Diagnostic Accuracy of Lipopolysaccharide-Binding Protein as Biomarker for Sepsis in Adult Patients: A Systematic Review and Meta-Analysis,” Plos One, vol. 11, no. 4, 2016. View at Publisher · View at Google Scholar
  • Iulia Karlsson, Ragnvi Hagman, Anders Johannisson, Liya Wang, Fredrik Sodersten, and Sara Wernersson, “Multiplex cytokine analyses in dogs with pyometra suggest involvement of KC-like chemokine in canine bacterial sepsis,” Veterinary Immunology And Immunopathology, vol. 170, pp. 41–46, 2016. View at Publisher · View at Google Scholar
  • Yong Liu, Qing Li, Kui-jun Chen, Shu-Nan Wang, Jian-min Wang, and Jun-huan Hou, “Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis,” SpringerPlus, vol. 5, no. 1, 2016. View at Publisher · View at Google Scholar
  • Jaap ten Oever, Mihai G. Netea, and Bart-Jan Kullberg, “Utility of immune response-derived biomarkers in the differential diagnosis of inflammatory disorders,” Journal Of Infection, vol. 72, no. 1, pp. 1–18, 2016. View at Publisher · View at Google Scholar
  • Chawika Pisitsak, and Keith R. Walley, “Does this patient have septic shock?,” Intensive Care Medicine, vol. 43, no. 3, pp. 429–432, 2016. View at Publisher · View at Google Scholar
  • Lars Ljungström, Anna-Karin Pernestig, Gunnar Jacobsson, Rune Andersson, Barbara Usener, and Diana Tilevik, “Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis.,” PloS one, vol. 12, no. 7, 2017. View at Publisher · View at Google Scholar
  • Steven M. Russell, Alejandra Alba-Patiño, Marcio Borges, and Roberto de la Rica, “A Robust and User-Friendly Alternative to Densitometry Using Origami Biosensors and Digital Logic,” ACS Sensors, 2018. View at Publisher · View at Google Scholar
  • Alexander R. Levine, Robyn Riggott, Kristela Vulaj, Tera R. Falcetti, Syed Ali, and Gagandeep Singh, “A Collaborative Approach to Improve Consistent Use of Procalcitonin in Lower-Respiratory-Tract Infections,” Annals of Pharmacotherapy, pp. 106002801775341, 2018. View at Publisher · View at Google Scholar